{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:05:23Z","timestamp":1793480723165,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071422"],"award-info":[{"award-number":["82071422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7212031"],"award-info":[{"award-number":["7212031"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00415-022-11556-3","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T15:03:17Z","timestamp":1673535797000},"page":"2451-2467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"270","author":[{"given":"Jianing","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongning","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0378-7764","authenticated-orcid":false,"given":"Tao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"11556_CR1","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","volume":"72","author":"MD Weingarten","year":"1975","unstructured":"Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72:1858\u20131862. https:\/\/doi.org\/10.1073\/pnas.72.5.1858","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11556_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11910-019-0962-7","volume":"19","author":"YT Wang","year":"2019","unstructured":"Wang YT, Edison P (2019) Tau imaging in neurodegenerative diseases using positron emission tomography. Curr Neurol Neurosci Rep 19:45. https:\/\/doi.org\/10.1007\/s11910-019-0962-7","journal-title":"Curr Neurol Neurosci Rep"},{"key":"11556_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/14737175.2018.1489241","volume":"18","author":"F Ali","year":"2018","unstructured":"Ali F, Josephs K (2018) The diagnosis of progressive supranuclear palsy: current opinions and challenges. Expert Rev Neurother 18:603\u2013616. https:\/\/doi.org\/10.1080\/14737175.2018.1489241","journal-title":"Expert Rev Neurother"},{"key":"11556_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259. https:\/\/doi.org\/10.1007\/bf00308809","journal-title":"Acta Neuropathol"},{"issue":"Suppl 2","key":"11556_CR5","doi-asserted-by":"publisher","first-page":"Ii6","DOI":"10.1007\/bf03161076","volume":"246","author":"DW Dickson","year":"1999","unstructured":"Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246(Suppl 2):Ii6-15. https:\/\/doi.org\/10.1007\/bf03161076","journal-title":"J Neurol"},{"key":"11556_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.semnuclmed.2020.12.004","volume":"51","author":"L Beyer","year":"2021","unstructured":"Beyer L, Brendel M (2021) Imaging of tau pathology in neurodegenerative diseases: an update. Semin Nucl Med 51:253\u2013263. https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.12.004","journal-title":"Semin Nucl Med"},{"key":"11556_CR7","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","volume":"24","author":"A Leuzy","year":"2019","unstructured":"Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E, Nordberg A (2019) Tau PET imaging in neurodegenerative tauopathies-still a challenge. Mol Psychiatry 24:1112\u20131134. https:\/\/doi.org\/10.1038\/s41380-018-0342-8","journal-title":"Mol Psychiatry"},{"key":"11556_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fnagi.2017.00440","volume":"9","author":"M Brendel","year":"2017","unstructured":"Brendel M, Sch\u00f6necker S, H\u00f6glinger G, Lindner S, Havla J, Blautzik J, Sauerbeck J, Rohrer G, Zach C, Vettermann F, Lang AE, Golbe L, N\u00fcbling G, Bartenstein P, Furukawa K, Ishiki A, B\u00f6tzel K, Danek A, Okamura N, Levin J, Rominger A (2017) [(18)F]-THK5351 PET correlates with topology and symptom severity in progressive supranuclear palsy. Front Aging Neurosci 9:440. https:\/\/doi.org\/10.3389\/fnagi.2017.00440","journal-title":"Front Aging Neurosci"},{"key":"11556_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1471-4159.2009.05996.x","volume":"109","author":"PW Thompson","year":"2009","unstructured":"Thompson PW, Ye L, Morgenstern JL, Sue L, Beach TG, Judd DJ, Shipley NJ, Libri V, Lockhart A (2009) Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer\u2019s disease pathologies. J Neurochem 109:623\u2013630. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.05996.x","journal-title":"J Neurochem"},{"key":"11556_CR10","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1001\/jamaneurol.2020.2526","volume":"77","author":"M Brendel","year":"2020","unstructured":"Brendel M, Barthel H, Van Eimeren T, Marek K, Beyer L, Song M, Palleis C, Gehmeyr M, Fietzek U, Respondek G, Sauerbeck J, Nitschmann A, Zach C, Hammes J, Barbe MT, Onur O, Jessen F, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Neumaier B, Barret O, Madonia J, Russell DS, Stephens A, Roeber S, Herms J, B\u00f6tzel K, Classen J, Bartenstein P, Villemagne V, Levin J, H\u00f6glinger GU, Drzezga A, Seibyl J, Sabri O (2020) Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy. JAMA Neurol 77:1408\u20131419. https:\/\/doi.org\/10.1001\/jamaneurol.2020.2526","journal-title":"JAMA Neurol"},{"key":"11556_CR11","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1177\/0271678x16683695","volume":"37","author":"S Coakeley","year":"2017","unstructured":"Coakeley S, Cho SS, Koshimori Y, Rusjan P, Harris M, Ghadery C, Kim J, Lang AE, Wilson A, Houle S, Strafella AP (2017) Positron emission tomography imaging of tau pathology in progressive supranuclear palsy. J Cerebr Blood Flow Metabol 37:3150\u20133160. https:\/\/doi.org\/10.1177\/0271678x16683695","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"11556_CR12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, M\u00fcller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, Van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, Van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord Offl J Mov Disord Soc 32:853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord Offl J Mov Disord Soc"},{"key":"11556_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/wnl.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1\u20139. https:\/\/doi.org\/10.1212\/wnl.47.1.1","journal-title":"Neurology"},{"key":"11556_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605. https:\/\/doi.org\/10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"11556_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clin Res) 327:557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ (Clin Res)"},{"key":"11556_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/jad-130032","volume":"36","author":"V Kepe","year":"2013","unstructured":"Kepe V, Bordelon Y, Boxer A, Huang SC, Liu J, Thiede FC, Mazziotta JC, Mendez MF, Donoghue N, Small GW, Barrio JR (2013) PET imaging of neuropathology in tauopathies: progressive supranuclear palsy. J Alzheimer\u2019s Dis 36:145\u2013153. https:\/\/doi.org\/10.3233\/jad-130032","journal-title":"J Alzheimer's Dis"},{"key":"11556_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mds.26844","volume":"32","author":"H Cho","year":"2017","unstructured":"Cho H, Choi JY, Hwang MS, Lee SH, Ryu YH, Lee MS, Lyoo CH (2017) Subcortical (18) F-AV-1451 binding patterns in progressive supranuclear palsy. Mov Disord 32:134\u2013140. https:\/\/doi.org\/10.1002\/mds.26844","journal-title":"Mov Disord"},{"key":"11556_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2967\/jnumed.116.174508","volume":"58","author":"A Hahn","year":"2017","unstructured":"Hahn A, Schain M, Erlandsson M, Sj\u00f6lin P, James GM, Strandberg OT, H\u00e4gerstr\u00f6m D, Lanzenberger R, J\u00f6gi J, Olsson TG, Smith R, Hansson O (2017) Modeling strategies for quantification of in vivo (18)F-AV-1451 binding in patients with tau pathology. J Nucl Med 58:623\u2013631. https:\/\/doi.org\/10.2967\/jnumed.116.174508","journal-title":"J Nucl Med"},{"key":"11556_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/ene.13164","volume":"24","author":"A Ishiki","year":"2017","unstructured":"Ishiki A, Harada R, Okamura N, Tomita N, Rowe CC, Villemagne VL, Yanai K, Kudo Y, Arai H, Furumoto S, Tashiro M, Furukawa K (2017) Tau imaging with [(18) F]THK-5351 in progressive supranuclear palsy. Eur J Neurol 24:130\u2013136. https:\/\/doi.org\/10.1111\/ene.13164","journal-title":"Eur J Neurol"},{"key":"11556_CR20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/brain\/aww340","volume":"140","author":"L Passamonti","year":"2017","unstructured":"Passamonti L, V\u00e1zquez Rodr\u00edguez P, Hong YT, Allinson KS, Williamson D, Borchert RJ, Sami S, Cope TE, Bevan-Jones WR, Jones PS, Arnold R, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O\u2019brien JT, Rowe JB, (2017) 18F-AV-1451 positron emission tomography in Alzheimer\u2019s disease and progressive supranuclear palsy. Brain J Neurol 140:781\u2013791. https:\/\/doi.org\/10.1093\/brain\/aww340","journal-title":"Brain J Neurol"},{"key":"11556_CR21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/mds.27029","volume":"32","author":"A Perez-Soriano","year":"2017","unstructured":"Perez-Soriano A, Arena JE, Dinelle K, Miao Q, Mckenzie J, Neilson N, Puschmann A, Schaffer P, Shinotoh H, Smith-Forrester J, Shahinfard E, Vafai N, Wile D, Wszolek Z, Higuchi M, Sossi V, Stoessl AJ (2017) PBB3 imaging in Parkinsonian disorders: evidence for binding to tau and other proteins. Mov Disord 32:1016\u20131024. https:\/\/doi.org\/10.1002\/mds.27029","journal-title":"Mov Disord"},{"key":"11556_CR22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ana.25060","volume":"82","author":"DR Schonhaut","year":"2017","unstructured":"Schonhaut DR, Mcmillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD Sr, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, Pressman P, Nasrallah I, Baker SL, Gomperts SN, Johnson KA, Grossman M, Jagust WJ, Boxer AL, Rabinovici GD (2017) (18) F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: a multicenter study. Ann Neurol 82:622\u2013634. https:\/\/doi.org\/10.1002\/ana.25060","journal-title":"Ann Neurol"},{"key":"11556_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/mds.26813","volume":"32","author":"R Smith","year":"2017","unstructured":"Smith R, Schain M, Nilsson C, Strandberg O, Olsson T, H\u00e4gerstr\u00f6m D, J\u00f6gi J, Borroni E, Sch\u00f6ll M, Honer M, Hansson O (2017) Increased basal ganglia binding of (18) F-AV-1451 in patients with progressive supranuclear palsy. Mov Disord 32:108\u2013114. https:\/\/doi.org\/10.1002\/mds.26813","journal-title":"Mov Disord"},{"key":"11556_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/mds.26834","volume":"32","author":"JL Whitwell","year":"2017","unstructured":"Whitwell JL, Lowe VJ, Tosakulwong N, Weigand SD, Senjem ML, Schwarz CG, Spychalla AJ, Petersen RC, Jack CR Jr, Josephs KA (2017) [(18) F]AV-1451 tau positron emission tomography in progressive supranuclear palsy. Mov Disord 32:124\u2013133. https:\/\/doi.org\/10.1002\/mds.26834","journal-title":"Mov Disord"},{"key":"11556_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00429-017-1507-y","volume":"223","author":"S Coakeley","year":"2018","unstructured":"Coakeley S, Cho SS, Koshimori Y, Rusjan P, Ghadery C, Kim J, Lang AE, Houle S, Strafella AP (2018) [(18)F]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP. Brain Struct Funct 223:589\u2013595. https:\/\/doi.org\/10.1007\/s00429-017-1507-y","journal-title":"Brain Struct Funct"},{"key":"11556_CR26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2018.12917","volume":"320","author":"R Ossenkoppele","year":"2018","unstructured":"Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Sch\u00f6ll M, Strandberg O, Palmqvist S, Mattsson N, Janelidze S, Santillo A, Ohlsson T, J\u00f6gi J, Tsai R, La Joie R, Kramer J, Boxer AL, Gorno-Tempini ML, Miller BL, Choi JY, Ryu YH, Lyoo CH, Hansson O (2018) Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders. JAMA 320:1151\u20131162. https:\/\/doi.org\/10.1001\/jama.2018.12917","journal-title":"JAMA"},{"key":"11556_CR27","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/mds.27643","volume":"34","author":"H Endo","year":"2019","unstructured":"Endo H, Shimada H, Sahara N, Ono M, Koga S, Kitamura S, Niwa F, Hirano S, Kimura Y, Ichise M, Shinotoh H, Zhang MR, Kuwabara S, Dickson DW, Toda T, Suhara T, Higuchi M (2019) In vivo binding of a tau imaging probe, [(11) C]PBB3, in patients with progressive supranuclear palsy. Mov Disord 34:744\u2013754. https:\/\/doi.org\/10.1002\/mds.27643","journal-title":"Mov Disord"},{"key":"11556_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fnagi.2019.00249","volume":"11","author":"S Sch\u00f6necker","year":"2019","unstructured":"Sch\u00f6necker S, Brendel M, Palleis C, Beyer L, H\u00f6glinger GU, Schuh E, Rauchmann BS, Sauerbeck J, Rohrer G, Sonnenfeld S, Furukawa K, Ishiki A, Okamura N, Bartenstein P, Dieterich M, B\u00f6tzel K, Danek A, Rominger A, Levin J (2019) PET imaging of astrogliosis and tau facilitates diagnosis of parkinsonian syndromes. Front Aging Neurosci 11:249. https:\/\/doi.org\/10.3389\/fnagi.2019.00249","journal-title":"Front Aging Neurosci"},{"key":"11556_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.parkreldis.2019.07.001","volume":"66","author":"I Sintini","year":"2019","unstructured":"Sintini I, Schwarz CG, Senjem ML, Reid RI, Botha H, Ali F, Ahlskog JE, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL (2019) Multimodal neuroimaging relationships in progressive supranuclear palsy. Parkinsonism Relat Disord 66:56\u201361. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.07.001","journal-title":"Parkinsonism Relat Disord"},{"key":"11556_CR30","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/ana.25893","volume":"88","author":"A Ghirelli","year":"2020","unstructured":"Ghirelli A, Tosakulwong N, Weigand SD, Clark HM, Ali F, Botha H, Duffy JR, Utianski RL, Buciuc M, Murray ME, Labuzan SA, Spychalla AJ, Pham NTT, Schwarz CG, Senjem ML, Machulda MM, Baker M, Rademakers R, Filippi M, Jack CR Jr, Lowe VJ, Parisi JE, Dickson DW, Josephs KA, Whitwell JL (2020) Sensitivity-specificity of tau and amyloid \u03b2 positron emission tomography in frontotemporal lobar degeneration. Ann Neurol 88:1009\u20131022. https:\/\/doi.org\/10.1002\/ana.25893","journal-title":"Ann Neurol"},{"key":"11556_CR31","doi-asserted-by":"publisher","first-page":"19410","DOI":"10.1038\/s41598-020-76339-0","volume":"10","author":"JL Hsu","year":"2020","unstructured":"Hsu JL, Chen SH, Hsiao IT, Lu CS, Yen TC, Okamura N, Lin KJ, Weng YH (2020) (18)F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty. Sci Rep 10:19410. https:\/\/doi.org\/10.1038\/s41598-020-76339-0","journal-title":"Sci Rep"},{"key":"11556_CR32","doi-asserted-by":"publisher","first-page":"102152","DOI":"10.1016\/j.nicl.2019.102152","volume":"25","author":"JL Whitwell","year":"2020","unstructured":"Whitwell JL, Tosakulwong N, Botha H, Ali F, Clark HM, Duffy JR, Utianski RL, Stevens CA, Weigand SD, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Ahlskog JE, Dickson DW, Josephs KA (2020) Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants. NeuroImage Clin 25:102152. https:\/\/doi.org\/10.1016\/j.nicl.2019.102152","journal-title":"NeuroImage Clin"},{"key":"11556_CR33","doi-asserted-by":"publisher","first-page":"761010","DOI":"10.3389\/fnagi.2021.761010","volume":"13","author":"M Ezura","year":"2021","unstructured":"Ezura M, Kikuchi A, Okamura N, Ishiki A, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T, Sugeno N, Yoshida S, Kobayashi J, Kobayashi M, Tano O, Ishiyama S, Nakamura T, Nakashima I, Mugikura S, Iwata R, Taki Y, Furukawa K, Arai H, Furumoto S, Tashiro M, Yanai K, Kudo Y, Takeda A, Aoki M (2021) (18)F-THK5351 positron emission tomography imaging in neurodegenerative tauopathies. Front Aging Neurosci 13:761010. https:\/\/doi.org\/10.3389\/fnagi.2021.761010","journal-title":"Front Aging Neurosci"},{"key":"11556_CR34","doi-asserted-by":"publisher","first-page":"646440","DOI":"10.3389\/fnagi.2021.646440","volume":"13","author":"CH Li","year":"2021","unstructured":"Li CH, Chen TF, Chiu MJ, Yen RF, Shih MC, Lin CH (2021) Integrated (18)F-T807 Tau PET, structural MRI, and plasma tau in tauopathy neurodegenerative disorders. Front Aging Neurosci 13:646440. https:\/\/doi.org\/10.3389\/fnagi.2021.646440","journal-title":"Front Aging Neurosci"},{"key":"11556_CR35","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/mds.28672","volume":"36","author":"L Li","year":"2021","unstructured":"Li L, Liu FT, Li M, Lu JY, Sun YM, Liang X, Bao W, Chen QS, Li XY, Zhou XY, Guan Y, Wu JJ, Yen TC, Jang MK, Luo JF, Wang J, Zuo C (2021) Clinical utility of (18) F-APN-1607 tau PET imaging in patients with progressive supranuclear palsy. Mov Disord 36:2314\u20132323. https:\/\/doi.org\/10.1002\/mds.28672","journal-title":"Mov Disord"},{"key":"11556_CR36","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262985","author":"M Malpetti","year":"2021","unstructured":"Malpetti M, Kaalund SS, Tsvetanov KA, Rittman T, Briggs M, Allinson K, Passamonti L, Holland N, Jones PS, Fryer TD, Hong YT, Kouli A, Bevan-Jones R, Mak E, Savulich G, Spillantini MG, Aigbirhio F, Williams-Gray CH, O\u2019brien JT, Rowe JB (2021) In vivo (18)F-flortaucipir PET does not accurately support the staging of progressive supranuclear palsy. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.121.262985","journal-title":"J Nucl Med"},{"key":"11556_CR37","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1007\/s00259-021-05391-3","volume":"48","author":"M Song","year":"2021","unstructured":"Song M, Scheifele M, Barthel H, Van Eimeren T, Beyer L, Marek K, Eckenweber F, Palleis C, Kaiser L, Finze A, Kern M, Nitschmann A, Biechele G, Katzdobler S, Bischof G, Hammes J, Jessen F, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Neumaier B, Stephens AW, Rauchmann BS, Perneczky R, Levin J, Classen J, H\u00f6glinger GU, Bartenstein P, Boening G, Ziegler S, Villemagne V, Drzezga A, Seibyl J, Sabri O, Brendel M (2021) Feasibility of short imaging protocols for [(18)F]PI-2620 tau-PET in progressive supranuclear palsy. Eur J Nucl Med Mol Imaging 48:3872\u20133885. https:\/\/doi.org\/10.1007\/s00259-021-05391-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11556_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2020.09.042","volume":"109","author":"K Tagai","year":"2021","unstructured":"Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C, Takado Y, Shinotoh H, Sano Y, Yamamoto Y, Matsuoka K, Takuwa H, Shimojo M, Takahashi M, Kawamura K, Kikuchi T, Okada M, Akiyama H, Suzuki H, Onaya M, Takeda T, Arai K, Arai N, Araki N, Saito Y, Trojanowski JQ, Lee VMY, Mishra SK, Yamaguchi Y, Kimura Y, Ichise M, Tomita Y, Zhang MR, Suhara T, Shigeta M, Sahara N, Higuchi M, Shimada H (2021) High-contrast in vivo imaging of tau pathologies in Alzheimer\u2019s and non-Alzheimer\u2019s disease tauopathies. Neuron 109:42-58.e48. https:\/\/doi.org\/10.1016\/j.neuron.2020.09.042","journal-title":"Neuron"},{"key":"11556_CR39","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen EH, La Joie R, Strom A, Fonseca C, Iaccarino L, Wolf A, Spina S, Allen IE, Cobigo Y, Heuer H, Vandevrede L, Proctor NK, Lago AL, Baker S, Sivasankaran R, Kieloch A, Kinhikar A, Yu L, Valentin MA, Jeromin A, Zetterberg H, Hansson O, Mattsson-Carlgren N, Graham D, Blennow K, Kramer JH, Grinberg LT, Seeley WW, Rosen H, Boeve BF, Miller BL, Teunissen CE, Rabinovici GD, Rojas JC, Dage JL, Boxer AL (2021) Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol 20:739\u2013752. https:\/\/doi.org\/10.1016\/s1474-4422(21)00214-3","journal-title":"Lancet Neurol"},{"key":"11556_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, Coughlin D, Giese A, Grossman M, Kurz C, Mcmillan CT, Gelpi E, Compta Y, Van Swieten JC, Laat LD, Troakes C, Al-Sarraj S, Robinson JL, Roeber S, Xie SX, Lee VM, Trojanowski JQ, H\u00f6glinger GU (2020) Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140:99\u2013119. https:\/\/doi.org\/10.1007\/s00401-020-02158-2","journal-title":"Acta Neuropathol"},{"key":"11556_CR41","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41582-021-00541-5","volume":"17","author":"M Stamelou","year":"2021","unstructured":"Stamelou M, Respondek G, Giagkou N, Whitwell JL, Kovacs GG, H\u00f6glinger GU (2021) Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies. Nat Rev Neurol 17:601\u2013620. https:\/\/doi.org\/10.1038\/s41582-021-00541-5","journal-title":"Nat Rev Neurol"},{"key":"11556_CR42","first-page":"904","volume":"39","author":"OG Rousset","year":"1998","unstructured":"Rousset OG, Ma Y, Evans AC (1998) Correction for partial volume effects in PET: principle and validation. J Nucl Med 39:904\u2013911","journal-title":"J Nucl Med"},{"key":"11556_CR43","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","volume":"58","author":"PT Meyer","year":"2017","unstructured":"Meyer PT, Frings L, R\u00fccker G, Hellwig S (2017) (18)F-FDG PET in parkinsonism: differential diagnosis and evaluation of cognitive impairment. J Nucl Med 58:1888\u20131898. https:\/\/doi.org\/10.2967\/jnumed.116.186403","journal-title":"J Nucl Med"},{"key":"11556_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/rlu.0000000000002949","volume":"45","author":"N Schr\u00f6ter","year":"2020","unstructured":"Schr\u00f6ter N, Blazhenets G, Frings L, Barkhausen C, Jost WH, Weiller C, Rijntjes M, Meyer PT (2020) Tau imaging in the 4-repeat-tauopathies progressive supranuclear palsy and corticobasal syndrome: A 11C-pyridinyl-butadienyl-benzothiazole 3 PET pilot study. Clin Nucl Med 45:283\u2013287. https:\/\/doi.org\/10.1097\/rlu.0000000000002949","journal-title":"Clin Nucl Med"},{"key":"11556_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158460","volume":"11","author":"SN Lockhart","year":"2016","unstructured":"Lockhart SN, Baker SL, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust WJ (2016) Dynamic PET measures of tau accumulation in cognitively normal older adults and Alzheimer\u2019s disease patients measured using [18F] THK-5351. PLoS ONE 11:e0158460. https:\/\/doi.org\/10.1371\/journal.pone.0158460","journal-title":"PLoS ONE"},{"key":"11556_CR46","doi-asserted-by":"publisher","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, Mckee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL, Wisniewski T, Woltjer RL, Yamada M, Nelson PT (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766. https:\/\/doi.org\/10.1007\/s00401-014-1349-0","DOI":"10.1007\/s00401-014-1349-0"},{"key":"11556_CR47","doi-asserted-by":"publisher","unstructured":"Hickman RA, Flowers XE, Wisniewski T (2020) Primary age-related tauopathy (PART): addressing the spectrum of neuronal tauopathic changes in the aging brain. Curr Neurol Neurosci Rep 20:39. https:\/\/doi.org\/10.1007\/s11910-020-01063-1","DOI":"10.1007\/s11910-020-01063-1"},{"key":"11556_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE, Kantarci K, Boeve BF, Pandey MK, Bruinsma T, Knopman DS, Jones DT, Petrucelli L, Cook CN, Graff-Radford NR, Dickson DW, Petersen RC, Jack CR Jr, Murray ME (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4:58. https:\/\/doi.org\/10.1186\/s40478-016-0315-6","journal-title":"Acta Neuropathol Commun"},{"key":"11556_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2967\/jnumed.117.197426","volume":"59","author":"R Harada","year":"2018","unstructured":"Harada R, Ishiki A, Kai H, Sato N, Furukawa K, Furumoto S, Tago T, Tomita N, Watanuki S, Hiraoka K, Ishikawa Y, Funaki Y, Nakamura T, Yoshikawa T, Iwata R, Tashiro M, Sasano H, Kitamoto T, Yanai K, Arai H, Kudo Y, Okamura N (2018) Correlations of (18)F-THK5351 PET with postmortem burden of tau and astrogliosis in Alzheimer disease. J Nucl Med 59:671\u2013674. https:\/\/doi.org\/10.2967\/jnumed.117.197426","journal-title":"J Nucl Med"},{"key":"11556_CR50","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/brain\/aww339","volume":"140","author":"M Ono","year":"2017","unstructured":"Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, Van Swieten JC, Nordberg A, Suhara T, Zhang MR, Higuchi M (2017) Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Brain J Neurol 140:764\u2013780. https:\/\/doi.org\/10.1093\/brain\/aww339","journal-title":"Brain J Neurol"},{"key":"11556_CR51","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","volume":"79","author":"M Maruyama","year":"2013","unstructured":"Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang MR, Trojanowski JQ, Lee VM, Ono M, Masamoto K, Takano H, Sahara N, Iwata N, Okamura N, Furumoto S, Kudo Y, Chang Q, Saido TC, Takashima A, Lewis J, Jang MK, Aoki I, Ito H, Higuchi M (2013) Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79:1094\u20131108. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.037","journal-title":"Neuron"},{"key":"11556_CR52","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/mds.27013","volume":"32","author":"S Koga","year":"2017","unstructured":"Koga S, Ono M, Sahara N, Higuchi M, Dickson DW (2017) Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to \u03b1-synuclein pathology. Mov Disord 32:884\u2013892. https:\/\/doi.org\/10.1002\/mds.27013","journal-title":"Mov Disord"},{"key":"11556_CR53","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","volume":"46","author":"H Kroth","year":"2019","unstructured":"Kroth H, Oden F, Molette J, Schieferstein H, Capotosti F, Mueller A, Berndt M, Schmitt-Willich H, Darmency V, Gabellieri E, Boudou C, Juergens T, Varisco Y, Vokali E, Hickman DT, Tamagnan G, Pfeifer A, Dinkelborg L, Muhs A, Stephens A (2019) Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer\u2019s disease and other tauopathies. Eur J Nucl Med Mol Imaging 46:2178\u20132189. https:\/\/doi.org\/10.1007\/s00259-019-04397-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11556_CR54","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41467-022-28896-3","volume":"13","author":"N Franzmeier","year":"2022","unstructured":"Franzmeier N, Brendel M, Beyer L, Slemann L, Kovacs GG, Arzberger T, Kurz C, Respondek G, Lukic MJ, Biel D, Rubinski A, Frontzkowski L, Hummel S, M\u00fcller A, Finze A, Palleis C, Joseph E, Weidinger E, Katzdobler S, Song M, Biechele G, Kern M, Scheifele M, Rauchmann BS, Perneczky R, Rullman M, Patt M, Schildan A, Barthel H, Sabri O, Rumpf JJ, Schroeter ML, Classen J, Villemagne V, Seibyl J, Stephens AW, Lee EB, Coughlin DG, Giese A, Grossman M, Mcmillan CT, Gelpi E, Molina-Porcel L, Compta Y, Van Swieten JC, Laat LD, Troakes C, Al-Sarraj S, Robinson JL, Xie SX, Irwin DJ, Roeber S, Herms J, Simons M, Bartenstein P, Lee VM, Trojanowski JQ, Levin J, H\u00f6glinger G, Ewers M (2022) Tau deposition patterns are associated with functional connectivity in primary tauopathies. Nat Commun 13:1362. https:\/\/doi.org\/10.1038\/s41467-022-28896-3","journal-title":"Nat Commun"},{"key":"11556_CR55","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000121388","volume":"5","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5:339\u2013346. https:\/\/doi.org\/10.1159\/000121388","journal-title":"Neurodegener Dis"},{"key":"11556_CR56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/nan.12037","volume":"40","author":"H Ling","year":"2014","unstructured":"Ling H, De Silva R, Massey LA, Courtney R, Hondhamuni G, Bajaj N, Lowe J, Holton JL, Lees A, Revesz T (2014) Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. Neuropathol Appl Neurobiol 40:149\u2013163. https:\/\/doi.org\/10.1111\/nan.12037","journal-title":"Neuropathol Appl Neurobiol"},{"key":"11556_CR57","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/s1474-4422(09)70042-0","volume":"8","author":"DR Williams","year":"2009","unstructured":"Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270\u2013279. https:\/\/doi.org\/10.1016\/s1474-4422(09)70042-0","journal-title":"Lancet Neurol"},{"key":"11556_CR58","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.arr.2017.03.002","volume":"36","author":"B Hall","year":"2017","unstructured":"Hall B, Mak E, Cervenka S, Aigbirhio FI, Rowe JB, O\u2019brien JT (2017) In vivo tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings. Age Res Rev 36:50\u201363. https:\/\/doi.org\/10.1016\/j.arr.2017.03.002","journal-title":"Age Res Rev"},{"key":"11556_CR59","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/bf00304466","volume":"84","author":"H Braak","year":"1992","unstructured":"Braak H, Jellinger K, Braak E, Bohl J (1992) Allocortical neurofibrillary changes in progressive supranuclear palsy. Acta Neuropathol 84:478\u2013483. https:\/\/doi.org\/10.1007\/bf00304466","journal-title":"Acta Neuropathol"},{"key":"11556_CR60","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/jnnp-2021-328586","volume":"93","author":"S Koga","year":"2022","unstructured":"Koga S, Josephs KA, Aiba I, Yoshida M, Dickson DW (2022) Neuropathology and emerging biomarkers in corticobasal syndrome. J Neurol Neurosurg Psychiatr 93:919\u2013929. https:\/\/doi.org\/10.1136\/jnnp-2021-328586","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"11556_CR61","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrneurol.2011.43","volume":"7","author":"N Kouri","year":"2011","unstructured":"Kouri N, Whitwell JL, Josephs KA, Rademakers R, Dickson DW (2011) Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol 7:263\u2013272. https:\/\/doi.org\/10.1038\/nrneurol.2011.43","journal-title":"Nat Rev Neurol"},{"key":"11556_CR62","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awq123","volume":"133","author":"H Ling","year":"2010","unstructured":"Ling H, O\u2019sullivan SS, Holton JL, Revesz T, Massey LA, Williams DR, Paviour DC, Lees AJ (2010) Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain J Neurol 133:2045\u20132057. https:\/\/doi.org\/10.1093\/brain\/awq123","journal-title":"Brain J Neurol"},{"issue":"Suppl 1","key":"11556_CR63","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson DW (2018) Neuropathology of Parkinson disease. Parkinsonism Relat Disord 46(Suppl 1):S30-s33. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.07.033","journal-title":"Parkinsonism Relat Disord"},{"key":"11556_CR64","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s007020200027","volume":"109","author":"KA Jellinger","year":"2002","unstructured":"Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson\u2019s disease. J Neural Transm 109:329\u2013339. https:\/\/doi.org\/10.1007\/s007020200027","journal-title":"J Neural Transm"},{"key":"11556_CR65","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","volume":"73","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN, Locascio JJ, Makaretz SJ, Schultz A, Caso C, Vasdev N, Sperling R, Growdon JH, Dickerson BC, Johnson K (2016) Tau positron emission tomographic imaging in the lewy body diseases. JAMA Neurol 73:1334\u20131341. https:\/\/doi.org\/10.1001\/jamaneurol.2016.3338","journal-title":"JAMA Neurol"},{"key":"11556_CR66","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1002\/mds.27894","volume":"34","author":"WG Meissner","year":"2019","unstructured":"Meissner WG, Fernagut PO, Dehay B, P\u00e9ran P, Traon AP, Foubert-Samier A, Lopez Cuina M, Bezard E, Tison F, Rascol O (2019) Multiple system atrophy: recent developments and future perspectives. Mov Disord 34:1629\u20131642. https:\/\/doi.org\/10.1002\/mds.27894","journal-title":"Mov Disord"},{"key":"11556_CR67","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2214\/ajr.19.22705","volume":"215","author":"H Tan","year":"2020","unstructured":"Tan H, Gu Y, Yu H, Hu P, Zhang Y, Mao W, Shi H (2020) Total-body PET\/CT: current applications and future perspectives. AJR Am J Roentgenol 215:325\u2013337. https:\/\/doi.org\/10.2214\/ajr.19.22705","journal-title":"AJR Am J Roentgenol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11556-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T13:06:04Z","timestamp":1682427964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11556-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["11556"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11556-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"assertion":[{"value":"30 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}